Beam Therapeutics to Participate in Upcoming September 2025 Investor Conferences
Provided By GlobeNewswire
Last update: Aug 25, 2025
CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that management will participate in fireside chats at the following upcoming investor conferences:
Read more at globenewswire.com
